Cargando…
Expression of PAX-5 in B Cell Hodgkin and Non Hodgkin Lymphoma
BACKGROUND: B-cell malignancies including Precursor B-cell lymphoblastic lymphoma/leukemia and Hodgkin Lymphoma show a wide spectrum of B-cell differentiation from early stage B-cell precursors to mature B-cells ending in terminal differentiation to plasma cells. Pan-B-cell antigens routinely used f...
Autores principales: | Khan, Muhammad Rahil, Ahmad, Arsalan, Kayani, Naila, Minhas, Khurram |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
West Asia Organization for Cancer Prevention
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6428548/ https://www.ncbi.nlm.nih.gov/pubmed/30583670 http://dx.doi.org/10.31557/APJCP.2018.19.12.3463 |
Ejemplares similares
-
Pax5 expression in non-Hodgkin's lymphomas and acute leukemias.
por: Zhang, Xianglan, et al.
Publicado: (2003) -
Level of PAX5 in differential diagnosis of non-Hodgkin's lymphoma
por: Bharti, Brij, et al.
Publicado: (2016) -
How the discovery of rituximab impacted the treatment of B-cell non-Hodgkin’s lymphomas
por: Mohammed, Raihan, et al.
Publicado: (2019) -
Association of Human Cytomegalovirus with Hodgkin’s Disease and Non-Hodgkin’s lymphomas
por: Mehravaran, Hamide, et al.
Publicado: (2017) -
Peripheral T Cell Non-Hodgkin's Lymphoma following Treatment of Hodgkin's Lymphoma
por: Chang, Sun Hee, et al.
Publicado: (2015)